期刊文献+

高效液相色谱法测定血浆中文拉法辛浓度及其在治疗药物监测中的应用 被引量:5

HPLC determination of venlafaxine in human serum and TDM application
原文传递
导出
摘要 目的建立人血中文拉法辛的测定方法,为临床应用和药动学研究提供分析手段。方法采用HPLC紫外检测法,流动相甲醇-水-四甲基乙二胺-冰醋酸(63∶37∶0.44∶0.37,v/v),Agilent Eclipse XDB-C18分离柱,UV检测波长为230nm,以安眠酮为内标,正戊烷提取。结果线性范围20~1 200μg.L-1,平均回收率为99.1%,日内日间RSD在1.1%~4.5%,且常用的其他抗抑郁药及安定类药物不干扰测定。结论本方法简单,分析速度快,灵敏度高,适用于临床血药浓度测定及药物动力学研究。 Objective To develop an HPLC method for the determination of venlafaxine in human plasma,and analyse the relation between serum clozapine level and its efficacy.Methods A mobile phase was methyl alcohol-water-tetramethylethylenediamine-acetic acid(63∶37∶0.44∶0.37,v/v),an Eclipse DXB-C18 column(150 mm×4.6 mm,5 μm) and UV detector with sensitivity of 0.01 AUFS,with methaqualone as a internal standard.The venlafaxine in the serum was extracted with pentane.The detection wavelength was 230 nm.Results The linear range was from 20 to 1 200 μg·L-1(r=0.999),and the detection limit was 10 ng(S/N=5).The average recovery in the serum was 99.1% and RSD was 1.1% and 4.5% for intra-day and inter-day.The optimal therapeutic concentration was estimated from 130 to 450 ng·mL-1 Conclusion This method is simple,rapid,sensitive,and reproducible.It can be used for clinical drug concentration analysis in the serum.
出处 《中南药学》 CAS 2011年第10期745-747,共3页 Central South Pharmacy
关键词 文拉法辛 血药浓度 高效液相色谱法 治疗药物监测 venlafaxine serum drug concentration HPLC therapy drug monitoring
  • 相关文献

参考文献14

二级参考文献43

  • 1钟薇,张石宁.HPIC法测定血清文拉法辛浓度[J].中国民康医学,2005,17(9):499-500. 被引量:7
  • 2石浩强,庄庆琪,蔡卫民.人血浆中文拉法辛浓度的HPLC测定及其药物动力学[J].中国医药工业杂志,2005,36(11):694-696. 被引量:8
  • 3何娟,周志凌,李焕德.HPLC-MS同时测定4种新型抗抑郁药物的血药浓度[J].药物分析杂志,2005,25(12):1428-1432. 被引量:16
  • 4Shams ME,Arneth B,Hiemke C,王小艳.CYP2D6的多态性与文拉法辛的临床效应[J].中国处方药,2006,5(10):26-26. 被引量:12
  • 5[1]Holliday SM,Benfield P.Venlafaxine:A review of its pharmacology and therapeutic potential in depression[J].Drugs,1995,49(2):280-294.
  • 6[2]Eap CB,Bertel-Laubscher R,Zullino D,et al.Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions:a case report[J].Pharmacopsychiatry,2000,33(3):112-115.
  • 7[3]Wang PC,Howell SR,Scatin J,et al.The disposition of venlafaxine enantiomers in dogs,rats,and humans receiving venlafaxine[J].Chirality,1992,4(2):84-90.
  • 8[5]Rudaz S,Stell C,Balant-Gorqia AE,et al.Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins[J].Journal of Pharmaceutical and Biomedical Analysis,2000,23(1):107-115.
  • 9[6]Bhatt J,Jangid A,Subbaiah G,et al.Liquid chromatography tandem mass spectrometry(LC-MS-MS)method for simultaneous determination of venlafaxine and its active metabolite O-desmethylvenlafaxine in human plasma[J].J Chromatogr B,2005,829(1-2):75-81.
  • 10[7]Fanali S,Catarcini P,Presutti C.Enantiomeric separation of acidic compounds of pharmaceutical interest by capillary electrochromatography employing glycopeptide antibiotic stationary phases[J].Journal of Chromatography A,2003 994(1-2):227-232.

共引文献38

同被引文献33

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部